NYSE: DHR
Danaher Corp Stock

DHR Price
$226.55
Fair Value Price
N/A
Market Cap
$158.02B
52 Week Low
$121.39
52 Week High
$227.45
P/E
47.69x
P/B
4.36x
P/S
7.23x
PEG
3.28x
Dividend Yield
0.31%
Revenue
$17.52B
Earnings
$3.47B
Gross Profit Margin
55.30%
Operating Margin
25.05%
Net Profit Margin
19.30%
Debt to Equity
0.97
Operating Cash Flow
$4B
Beta
0.83
Next Earnings
Oct 22, 2020
Ex-Dividend
Sep 25, 2020
Next Dividend
Oct 30, 2020

Zen Score

High
Medium
Low
37
Industry average

Reasons for this score

DHR ($226.55) is trading below its intrinsic value of $304.48, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
DHR is poor value based on its earnings relative to its share price (47.69x), compared to the US market average (38.92x)
Valuation
DHR is poor value based on its earnings relative to its share price (47.69x), compared to the US Diagnostics & Research industry average (40.55x)
Valuation

1 of 13

DHR News

Valuation

DHR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
47.69x
Industry
40.55x
Market
38.92x
DHR is poor value based on its earnings relative to its share price (47.69x), compared to the US market average (38.92x)
Valuation
DHR is poor value based on its earnings relative to its share price (47.69x), compared to the US Diagnostics & Research industry average (40.55x)
Valuation

DHR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.36x
Industry
13.12x
Market
65.04x
DHR is good value based on its book value relative to its share price (4.36x), compared to the US market average (65.04x)
Valuation
DHR is good value based on its book value relative to its share price (4.36x), compared to the US Diagnostics & Research industry average (13.12x)
Valuation

DHR price to earnings growth (PEG)

For valuing profitable companies with growth potential
DHR is poor value relative to its rate of earnings growth, measured by PEG ratio (3.28x)
Valuation

DHR's financial health

Profit margin

Revenue
$4.3B
Net Income
$595.1M
Profit Margin
13.30%
DHR's Earnings (EBIT) of $4.39B can safely cover interest payments on company debt ($22.39B)
Financials
DHR's profit margin has increased (+4.00%) in the last year from (15.30%) to (19.30%)
Financials

Assets to liabilities

Assets
$68.9B
Liabilities
$37.9B
Debt to equity
0.84
DHR's short-term assets ($12.34B) exceed its short-term liabilities ($5.60B)
Financials
DHR's long-term liabilities ($29.40B) exceed its short-term assets ($12.34B)
Financials
DHR's debt has increased relative to shareholder equity (0.97), over the past 5 years ago (0.53)
Financials
DHR's debt to equity ratio (0.97) is considered high
Financials

Cash flow

Operating
$819.0M
Investing
-$20.9B
Financing
$4.6B
DHR's operating cash flow ($4.34B) may not be sufficient to safely service the company's debt ($22.39B)
Financials

Danaher Corp Stock FAQ

(NYSE: DHR) Danaher Corp trades on the NYSE under the ticker symbol DHR. Danaher Corp stock quotes can also be displayed as NYSE: DHR.
(NYSE: DHR) Danaher Corp stock price per share is $226.55 today (as of Oct 21, 2020).
(NYSE: DHR) Danaher Corp's 52-week high was $227.45, and its 52-week low was $121.39. It is currently -0.40% from its 52-week high and 86.63% from its 52-week low.
(NYSE: DHR) Danaher Corp's market cap is $158.02B, as of Oct 22, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Danaher Corp's market cap is calculated by multiplying DHR's current stock price of $226.55 by DHR's total outstanding shares of 697,511,185.
(NYSE: DHR) Danaher Corp currently has 697,511,185 outstanding shares. With Danaher Corp stock trading at $226.55 per share, the total value of Danaher Corp stock (market capitalization) is $158.02B.

Danaher Corp stock was originally listed at a price of $7.89 in Dec 31, 1997. If you had invested in Danaher Corp stock at $7.89, your return over the last 22 years would have been 2,770.99%, for an annualized return of 16.49%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics